MUSICK, PEELER & GARRETT NAMED “BEST LAW FIRM” BY BEST LAWYERS
LOS ANGELES, Nov. 3, 2023 /PRNewswire/ — Musick, Peeler & Garrett LLP announced today that it has been recognized by Best Lawyers® among the nation’s elite law firms for 2024. This list is compiled annually by U.S. News & World Report and Best Lawyers®. Rankings by Best La
Tea Tree Oil Market Set to Reach $69.0 Million by 2028, Fueled by Growing Consumer Demand for Natural Remedies
DUBLIN, Nov. 3, 2023 /PRNewswire/ — The “Tea Tree Oil Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The global tea tree oil market, valued at US$ 51.0 million in 2022, is a
Automotive Exhaust Manifold Market size to grow by USD 735.08 million from 2023 to 2028 | Market is fragmented due to the presence of prominent companies like Benteler International AG, BG Products Inc. and BorgWarner Inc., and many more
NEW YORK, Nov. 3, 2023 /PRNewswire/ — The Automotive Exhaust Manifold Market is estimated to increase by USD 735.08 million, accelerating at a CAGR of 5.4% during the forecast period. The automotive exhaust manifold market is fragmented owing to the presence of many global and regional comp
3D Ultrasound Market is to grow by USD 1.33 billion from 2023 to 2028- Technavio
NEW YORK, Nov. 3, 2023 /PRNewswire/ — The 3D ultrasound market is expected to grow by USD 1.33 billion from 2023 to 2028. In addition, the momentum of the market will progress at a CAGR of 6.82% during the forecast period, according to Technavio Research. The market has been segmented by e
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Li-Cycle Holdings Corp. – LICY
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Li-Cycle Holdings Corp. (“Li-Cycle” or the “Company”) (NYSE: LICY). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-652
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XPEL, Inc. – XPEL
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of XPEL, Inc. (“XPEL” or the “Company”) (NASDAQ: XPEL). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 798
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GrafTech International Ltd. – EAF
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of GrafTech International Ltd. (“GrafTech” or the “Company”) (NYSE: EAF). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-4
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of John Wiley & Sons, Inc. – WLY
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of John Wiley & Sons, Inc. (“Wiley” or the “Company”) (NYSE: WLY). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476
Mirati Therapeutics Receives Approval from the MHRA for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation
SAN DIEGO and ZUG, Switzerland, Nov. 3, 2023 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a commercial stage biotechnology company, today announced the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) granted conditional marketing authorization app
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of R1 RCM Inc. – RCM
NEW YORK, Nov. 3, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of R1 RCM Inc. (“RCM” or the “Company”) (NASDAQ: RCM). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980